Modified Aloe barbadensis Polysaccharide with Immunoregulatory Activity

Abstract

Aloe barbadensis polysaccharide was partially digested with cellulase and further purified by dialysis, stepwise ethanol precipitation, and size exclusion chromatography. Crude modified Aloe polysaccharide (MAP) activated macrophage cells and stimulated fibroblast growth. Under the same conditions, native Aloe barbadensis gel had no effect on macrophage activation. MAP prevented ultraviolet B (UVB) irradiation-induced immune suppression as determined by contact hypersensitivity (CHS) response in C3H/HeN mice. This in vivo activity was correlated with the activity of MAP to inhibit UVB irradiation-induced tumor necrosis factor α (TNF-α) release from human epidermoid carcinoma cells (KB cells). MAP with an average molecular weight of 80,000 Dalton (Da) contained mannose, galactose, and glucose in a ratio of 40 : 1.4 : 1.0. MAP was likely a linear, highly acetylated molecule.

Abbreviations

MAP:modified Aloe polysaccharide

UVB:Ultraviolet B

CHS:contact hypersensitivity

TNF-α:Tumor necrosis factor α

DNFB:dinitrofluorobenzene

KB cells:human epidermoid carcinoma cells

Aloe barbadensis Miller - Asphodelaceae - polysaccharide - macrophage activation - contact hypersensitivity - UVB irradiation

References

• 1 Roesler  J,, Emmendorffer  A,, Steinmuller  C,, Luettig  B,, Wagner  H,, Lohmann-Matthes  M-L.. .  Int. J. Immunopharmac.. 1991;;  13 931-941
• 2 Wong  C K,, Leung  K N,, Fung  K P,, Choy  Y M.. .  Immunopharmacology. 1994;;  28 47-54
• 3 Heggers  J P,, Pelley  R P,, Robson  M C.. .  Phytother. Res.. 1993;;  7 S48-S52
• 4 Vázquez  B,, Avila  G,, Segura  D,, Escalante  B.. .  J. Ethnopharmac.. 1996;;  55 69-75
• 5 Strickland  F M,, Pelley  R P,, Kripke  M L.. .  J. Invest. Dermatol.. 1994;;  102 197-204
• 6 Byeon  S W,, Pelley  R P,, Ullrich  S E,, Waller  T A,, Bucana  C D,, Strickland  F M.. .  J. Invest. Dermatol.. 1998;;  110 811-817
• 7 Dubois  M,, Gilles  K,, Hamilton  J,, Rebers  P,, Smith  F.. .  Anal. Chem.. 1956;;  28 350
• 8 Olechno  J,, Carter  S,, Edwards  W,, Gillen  D.. .  American Biotech. Lab.. 1987;;  5 38-50
• 9 Hakomori  S.. .  J. Biochem.. 1964;;  55 205-208
• 10 Ciucanu  I,, Kerek  F.. .  Carbohydr. Res.. 1984;;  131 209-217
• 11 Qiu  Z,, de Carvalho  M S,, Lesile  C C.. .  J. Biol. Chem.. 1993;;  268 24506-24513
• 12 Abrams  J S.. Current Protocols in Immunology,. Coligan J, Kruisbeek A, Margulies D, Shevach E, Strober W, eds. John Wiley and Sons, New York; 1995: 6-20
• 13 Mosmann  T.. .  J. Immunol. Methods. 1983;;  65 55-63
• 14 Mannel  D N,, Moore  R N,, Mergenhagen  S E.. .  J. Infect. Immun.. 1980;;  30 523
• 15 Davis  R,, Agnew  P,, Shapiro  E.. .  Pa. Acad. Sci.. 1984;;  58 114
• 16 . Progress in Clinical and Biological Research,. Watson SW, Levin WJ, Novitsky TJ, (eds.) Alan R. Liss, Inc., NY; 1987: 231
• 17 Kripke  M L.. .  J. Natl. Cancer Inst.. 1974;;  53 1333-1336
• 18 Yoshikawa  T,, Streilein  J W.. .  Reg. Immunol.. 1991;;  3 139-144
• 19 Vincek  V,, Kurimoto  I,, Medema  J P,, Pristo  E,, Streilein  J W.. .  Cancer Research. 1993;;  53 728-732
• 20 Winters  W D,, Benavides  R,, Clouse  W J.. .  Economic Botany . 1981;;  35 89-95
• 21 Yagi  A,, Egusa  T,, Arase  M,, Tanabe  M,, Tsuji  H.. .  Planta Med.. 1997;;  63 18-21
• 22 Mandal  G,, Das  A.. .  Carbohydrate Research. 1980;;  87 249-256
• 23 Yoshimoto  K,, Itatani  Y,, Tsuda  Y.. .  Chem. Pharm. Bull.. 1980;;  28 2065-2076
• 24 Yagi  A,, Nishimura  H,, Shida  T,, Nishioka  I.. .  Planta Med.. 1986;;  52 213-218